Advancing the Understanding of Heart Disease Detection
Providing new insights into the causes and mechanisms underlying heart diseases through original research and published findings.
Bridging the Diagnostic Gap in Heart Disease
- Most patients with heart disease are asymptomatic.
- Physicians have limited front-line technology options to detect heart disease.
- Most advanced diagnostic tests are expensive and require referral.
- Payors often discourage advanced diagnostics for asymptomatic patients.
Clinical Publications
Publications Coronary artery calcium (CAC) scoring is an established tool for cardiovascular risk stratification. However, the lack of widespread availability and concerns about radiation exposure have limited the universal clinical…
Publications A quantitative prediction of myocardial relaxation can be performed using easily obtained clinical and ECG features. This cost-effective strategy may be a valuable first clinical step for assessing the…
Publications Study demonstrates MyoVista® wavECG™ ability to cost-effectively detect LV DysfunctionSOUTHLAKE, Texas, August 18, 2020 – HeartSciences, a medical device company focused on advancing the field of electrocardiology through innovation,…
Publications The field of cardiovascular medicine has long been at the forefront of innovation. Innovations in data science, particularly machine learning (ML) and artificial intelligence (AI), have generated enthusiasm in…
Certifications
Reg. US Pat. & TM off.
All Rights Reserved.
Powered by Collective42
HeartSciences’ AI-ECG products are currently in development and not commercially available in the United States.
wavECG and wavEKG are trademarks of HeartSciences.
MV-WBSTE-002 Rev A